Work

Faculty Opinions recommendation of Nivolumab plus ipilimumab in advanced melanoma.

Year: 2013

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.718016388.793480571

Author: Mark Faries

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4247701075

Cites:

Cited by:

Related to: 6